Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STOP Vertigo: Supplementation of Vitamin D for Termination of Recurrences From Benign Paroxysmal Positional Vertigo

NCT05863949 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT05863949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05863949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STOP Vertigo: Supplementation of Vitamin D for Termination of Recurrences From Benign Paroxysmal Positional Vertigo
Lead sponsor
Ottawa Hospital Research Institute
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 31, 2025
Completion date
September 30, 2026
Enrollment
860 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

benign paroxysmal positional vertigo, bppv, calcium deficiency, dizziness, dizziness; epidemic, vertigo, vertigo, peripheral, vitamin d deficiency